Pfizer Raises Drug Prices by an Average of Nearly 9%

File this under “What controversy?”

Last week, Pfizer increased the list prices of its medicines in the United States by an average of 8.8 percent, according to an investor note by Morgan Stanley analyst David Risinger.

This marks the second time this year that the drug maker has substantially boosted prices for its prescription drugs. Back on Jan. 1, pfizer raised prices by an average of 10.4 percent, Risinger pointed out.